Elliott Vichinsky, MD: Voxelotor and New HOPE Data

from HCPLive Podcasts · host HCPLive.com

The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.

Episode metadata supplied by the publisher feed · Published Dec 8, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Elliott Vichinsky, MD: Voxelotor and New HOPE Data

0:00 24:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 24 minutes long.

This episode was published on December 8, 2020.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!